From: Aspirin use and risk of breast cancer in African American women
 |  | All invasive (n = 1919) | ER-positive (n = 1112) | ER-negative (n = 569) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Person-years | Cases | HRa | 95% CI | HRb | 95% CI | Cases | HRa | 95% CI | HRb | 95% CI | Cases | HRa | 95% CI | HRb | 95% CI | |
Aspirin use | ||||||||||||||||
 Non-use | 676,158 | 1226 | 1.00 | Reference | 1.00 | Reference | 662 | 1.00 | Reference | 1.00 | Reference | 385 | 1.00 | Reference | 1.00 | Reference |
 Past use | 143,880 | 325 | 0.95 | 0.83, 1.08 | 0.97 | 0.85, 1.10 | 207 | 0.97 | 0.83, 1.14 | 0.98 | 0.83, 1.16 | 92 | 0.88 | 0.69, 1.11 | 0.92 | 0.72, 1.17 |
 Current use | 150,151 | 368 | 0.89 | 0.79, 1.01 | 0.92 | 0.81, 1.04 | 243 | 0.97 | 0.83, 1.13 | 0.98 | 0.84, 1.15 | 92 | 0.77 | 0.61, 0.98 | 0.81 | 0.64, 1.04 |
Duration of current use | ||||||||||||||||
 Current, < 5 years | 73,790 | 173 | 0.91 | 0.77, 1.07 | 0.93 | 0.79, 1.09 | 108 | 0.98 | 0.80, 1.21 | 1.00 | 0.81, 1.23 | 43 | 0.75 | 0.55, 1.04 | 0.79 | 0.57, 1.09 |
 Current, 5–10 years | 41,940 | 117 | 0.96 | 0.79, 1.17 | 0.98 | 0.80, 1.19 | 82 | 1.09 | 0.86, 1.38 | 1.09 | 0.86, 1.39 | 28 | 0.80 | 0.54, 1.19 | 0.85 | 0.57, 1.27 |
 Current, ≥ 10 years | 34,422 | 78 | 0.77 | 0.61, 0.91 | 0.81 | 0.63, 1.03 | 53 | 0.78 | 0.58, 1.05 | 0.81 | 0.60, 1.09 | 21 | 0.76 | 0.48, 1.21 | 0.82 | 0.51, 1.31 |
Acetaminophen use | ||||||||||||||||
 Non-use | 681,495 | 1340 | 1.00 | Reference | 1.00 | Reference | 755 | 1.00 | Reference | 1.00 | Reference | 406 | 1.00 | Reference | 1.00 | Reference |
 Past use | 208,818 | 439 | 0.94 | 0.84, 1.05 | 0.96 | 0.86, 1.08 | 283 | 0.98 | 0.85, 1.12 | 0.99 | 0.86, 1.15 | 119 | 0.83 | 0.67, 1.02 | 0.87 | 0.71, 1.08 |
 Current use | 79,876 | 140 | 0.85 | 0.71, 1.02 | 0.88 | 0.74, 1.05 | 74 | 0.86 | 0.67, 1.09 | 0.88 | 0.68, 1.12 | 44 | 0.91 | 0.67, 1.25 | 0.95 | 0.69, 1.31 |